C. Jacobs

发表

A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia.

C. Jacobs, M. van der Pas, 1996, Oncology.

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

H. Wakelee, D. Dunlop, R. Ramlau, 2012, Cancer Chemotherapy and Pharmacology.

Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec

G. Demetri, K. Ganjoo, Shreyaskumar R Patel, 2009, Leukemia & lymphoma.

Distant metastases from head and neck squamous cancer: the role of adjuvant chemotherapy.

C. Jacobs, H. Pinto, 1995, Cancer treatment and research.

Adjuvant chemotherapy for head and neck cancer.

C. Jacobs, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group

W. Fee, D. Goffinet, C. Jacobs, 1987, Cancer.

Imatinib in the treatment of nephrogenic systemic fibrosis.

R. Lafayette, C. Jacobs, D. Fiorentino, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

CASE REPORTS Imatinib in the Treatment of Nephrogenic Systemic Fibrosis

R. Lafayette, C. Jacobs, D. Fiorentino, 2009 .

Phase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief report

H. Wakelee, C. Jacobs, A. Lopez-Anaya, 2013, Anti-cancer drugs.

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

H. Wakelee, C. Takimoto, E. Rowinsky, 2012, Cancer Chemotherapy and Pharmacology.

Head and neck cancer in 1994: a change in the standard of care.

C. Jacobs, 1994, Journal of the National Cancer Institute.

Naproxen sodium in treatment of bone pain due to metastatic cancer

F. Meyskens, C. Jacobs, D. Gordon, 1988, Pain.

Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor

D. Witten, K. Ganjoo, C. Jacobs, 2009, Case Reports in Oncology.

Etiologic considerations for head and neck squamous cancers.

C. Jacobs, 1990, Cancer treatment and research.

Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity.

A. B. Campbell, C. Jacobs, S. Kalman, 1983, Cancer treatment reports.

Malignant lymphoma with a high content of epithelioid histiocytes. A distinct clinicopathologic entity and a form of so‐called „Lennert's Lymphoma”︁

R. Warnke, R. Dorfman, C. Jacobs, 1978, Cancer.

Head and neck squamous cancers.

W. Fee, D. Goffinet, C. Jacobs, 1990, Current problems in cancer.

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.

R. Makuch, B. Vikram, G. Wolf, 1986, Cancer.

The internist in the management of head and neck cancer.

C. Jacobs, 1990, Annals of internal medicine.

Changing role of chemotherapy in treatment of head and neck cancer.

G. Mead, C. Jacobs, G. Mead, 1982, The American journal of medicine.

Primary paraspinal leiomyosarcoma invading the cervical spinal canal successfully treated with surgery, radiotherapy, and chemotherapy. Case report.

N. Lehman, I. Gibbs, L. Shuer, 2007, Journal of neurosurgery. Spine.

Prednisone in MOPP chemotherapy for Hodgkin's disease.

S. Rosenberg, C. Jacobs, C. Portlock, 1976, British medical journal.

The use of probenecid as a chemoprotector against cisplatin nephrotoxicity

C. Coleman, B. Sikic, C. Jacobs, 1991, Cancer.

Modification of cisplatin toxicity with diethyldithiocarbamate.

B. Sikic, C. Jacobs, R. Borch, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carcinomas of the Head and Neck

C. Jacobs, 1990, Cancer Treatment and Research.

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

E. Vokes, M. Collier, I. Dimery, 1991, Cancer.

The Value of Surgery for Retroperitoneal Sarcoma

J. Norton, S. Gholami, C. Jacobs, 2009, Sarcoma.

Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.

Jeffrey M. Hausdorff, C. Jacobs, M. van der Pas, 1997, The cancer journal from Scientific American.

Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.

S. Horning, S. Rosenberg, C. Jacobs, 1987, Cancer treatment reports.

A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.

R. Advani, B. Sikic, C. Jacobs, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant and neoadjuvant treatment of head and neck cancers.

C. Jacobs, 1991, Seminars in oncology.

Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations.

M. Weiner, C. Jacobs, J. Kosek, 1980, The Journal of pharmacology and experimental therapeutics.

24‐Hour infusion of cis‐platinum in head and neck cancers

J. Bertino, W. Fee, D. Goffinet, 1978, Cancer.

The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.

S. Rosenberg, R. Hoppe, C. Jacobs, 1985, International journal of radiation oncology, biology, physics.

The use of chemotherapy in combination with radiotherapy in the treatment of head and neck squamous cancers

C. Jacobs, 1984 .

Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys.

M. Weiner, C. Jacobs, J. Levi, 1980, The Journal of pharmacology and experimental therapeutics.

Management of the pregnant patient with Hodgkin's disease.

S. Donaldson, C. Jacobs, H. Kaplan, 1981, Annals of internal medicine.

Soft Tissue Sarcoma

D. Ettinger, G. Demetri, M. Heslin, 1999 .

Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590)

R. Arusell, P. Rubin, B. Burtness, 2017, Cancer.

The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma: A Single Institution Study

R. Tibshirani, R. West, D. Witten, 2011, American journal of clinical oncology.

Occult primary.

D. Ettinger, A. Rashid, L. Kvols, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Renal handling of cis-diamminedichloroplatinum(II).

M. Weiner, C. Jacobs, S. Kalman, 1980, Cancer treatment reports.

The treatment advice of a computer-based cancer chemotherapy protocol advisor.

Edward H. Shortliffe, David H. Hickam, Miriam B. Bischoff, 1985, Annals of internal medicine.

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

G. Lyman, W. Knight, L. Einhorn, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.

R. Makuch, C. Jacobs, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

K. Fu, T. Phillips, S. Carter, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's lymphomas of head and neck extranodal sites.

R. Hoppe, C. Jacobs, 1985, International journal of radiation oncology, biology, physics.

Use of methotrexate and 5-FU for recurrent head and neck cancer.

C. Jacobs, 1982, Cancer treatment reports.

Antiangiogenesis agents in the treatment of soft tissue sarcomas

K. Ganjoo, C. Jacobs, 2010, Cancer.

Mechanism of cisplatin nephrotoxicity.

M. Weiner, C. Jacobs, Weiner Mw, 1983, Federation proceedings.

Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.

C. Coleman, T. Phillips, S. Leibel, 1983, Cancer research.

Chapter 6 – THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF HEAD AND NECK CANCER

C. Jacobs, 1985 .

A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California oncology group study

C. Jacobs, M. Kohler, C. Hendrickson, 1983, Cancer.

High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer.

C. Jacobs, 1981, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

THE ROLE OF CISPLATIN IN THE TREATMENT OF RECURRENT HEAD AND NECK CANCER

C. Jacobs, 1980 .

Cis-Platinum Chemotherapy in Head and Neck Cancers

J. Bertino, W. Fee, C. Jacobs, 1978, Otolaryngology.

Treatment of nasopharyngeal carcinoma with human leukocyte interferon.

T. Merigan, J. Connors, W. Andiman, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The management of extranodal head and neck lymphomas.

R. Hoppe, L. Weiss, C. Jacobs, 1986, Archives of otolaryngology--head & neck surgery.

Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin.

S. Horning, S. Rosenberg, C. Jacobs, 1987, Cancer treatment reports.

Management of the Pregnant Patient with Hodgkinʼs Disease

S. Donaldson, C. Jacobs, H. Kaplan, 1982 .

Influence of interferon on the replication of oncogenic herpesviruses in tissue cultures and in nonhuman primates

C. Jacobs, R. Laufs, H. Karges, 2005, Medical Microbiology and Immunology.

Inhibition of c/s-Diamminedichloroplatinum Secretion by the Human Kidney with Probenecid1

M. Weiner, C. Coleman, C. Jacobs, 2006 .

Probenecid and Diethyldithiocarbamate as Modifiers of Cisplatin Toxicity

C. Jacobs, 1991 .

Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.

M. Weiner, C. Coleman, C. Jacobs, 1984, Cancer research.

Lymphomas of extranodal head and neck sites

C. Jacobs, 1987 .

ONCOCIN: An Expert System for Oncology Protocol Management

Edward H. Shortliffe, A. Carlisle Scott, Miriam B. Bischoff, 1981, IJCAI.

Chemotherapy for recurrent and metastatic head and neck cancer.

C. Jacobs, H. Pinto, 1991, Hematology/oncology clinics of North America.

Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases

C. Jacobs, Adam D. Elkin, 2008, Journal of Cancer Research and Clinical Oncology.

Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group.

K. Fu, A. Venook, F. Meyers, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant interferon-gamma in the treatment of recurrent nasopharyngeal carcinoma.

I. Dimery, C. Jacobs, Hong Wk, 1989, Journal of Biological Response Modifiers.

Nasopharyngeal carcinoma: relationship to Epstein-Barr virus and treatment with interferon

J. Connors, C. Jacobs, 1987 .

Head and neck cancer with an occult primary tumor.

C. Jacobs, H. Pinto, 1992, The New England journal of medicine.